home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Courses and Workshops  

Pharmaceutical Process Validation Basics

  September 22, 2009  
The Center for Professional Advancement, 90 Minute Accredited Online Training
November 24, 2009 at 11:00 a.m.–12:30 p.m. (ET)

Who Should Attend
This online training course is intended for managers, supervisors, engineers, chemists, scientists, technicians and formulators working within the Pharmaceutical, and related industries. It will also be valuable to documentation specialists, auditors and those in regulatory affairs. Personnel from the following departments will find the course beneficial:

  • Research and Development 
  • Quality Assurance and Control 
  • Manufacturing/Operations
  • Facilities 
  • Finance
  • IT

This training will also benefit suppliers of equipment and services to the industry.

In recent years, the FDA has placed intense focus on Process Validation. This 90-minute accredited online course will examine how we have reached the present validation environment and will give you a means for survival. It will provide a step-by-step guide to planning and preparing for process validation, and includes a discussion of how to write validation protocols, handle deviations, report validation results and “maintain the validated state.” The course provides a guide on how to manage the validation process efficiently and pragmatically. Further, this course provides “content understanding” so important for auditing validation activities as required in today's FDA regulated industry environment.

Module 1:
  • How did we reach the present validation environment?
  • Why do I need to validate processes?
  • What is process validation?
  • Does every process need to be validated?
  • Which processes are considered highest risk and will get 
    the most scrutiny?

Module 2:   • The Validation Master Plan
  • Basics of validation
  • URS, DQ, FAT, IQ, OQ, PQ: What are all these letters in 
    the alphabet soup?
  • Protocol Basics and Content

Module 3:
  • Handling Deviations
  • Validation Reports
  • Proper validation timing
  • Maintaining the validated state
  • Auditing Metrics for the Validation System

Question and Answer Session

Organized by: The Center for Professional Advancement
Invited Speakers: William G. Marshall, President of William G. Marshall and Associates; Consultant to the worldwide drug and device industry as well as to the FDA and worldwide lecturer in GMP related issues.

William G. Marshall is President of William G. Marshall and Associates. He has over twenty years experience in the Pharmaceutical and Medical Device Manufacturing Environment. Mr. Marshall has held Director level and Chief Operating Officer positions with large multinational pharmaceutical corporations as well as start-up ventures. He has been the Director of a major reference laboratory, and has been active in clean room design and validation. In the last five years, he has acted as a third party in several consent decrees.

Mr. Marshall is currently a consultant to the worldwide drug and device industry as well as to the FDA. He lectures worldwide in GMP related issues including Clean Room Technology and Sterilization. In the past 18 months, he has been involved in 10 Pre-Approval Inspections that include the first aseptic processed injectables from India, the first ever drugs from Turkey, and APIs from China, that were all approved for introduction to the US market. He has a Master's Degree in Biology from Georgetown University, Washington, DC.
Deadline for Abstracts: n/a
Registration: Please click here for registration information.
E-mail: salbers@cfpa.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.